Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003474084 | SCV004203723 | likely pathogenic | Hemochromatosis type 3 | 2022-01-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003750975 | SCV004392739 | pathogenic | Hereditary hemochromatosis | 2023-07-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp489*) in the TFR2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TFR2 are known to be pathogenic (PMID: 23600741, 26029709). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TFR2-related conditions. For these reasons, this variant has been classified as Pathogenic. |